CoChat
Sign Up
Cited by 56

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Pregnant women’s knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines

Giles, Michelle L, Buttery, Jim, Davey, Mary-Ann, Wallace, Euan·2019·Vaccine
DOI 10.1016/j.vaccine.2019.08.084
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2019.08.084

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 37

  1. Saji, 1999, Dynamics of immunoglobulins at the feto-maternal interface, Rev Reprod, 4, 81, 10.1530/ror.0.0040081 · DOI
  2. Keller-Stanislawski, 2014, Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines, Vaccine, 32, 7057, 10.1016/j.vaccine.2014.09.052 · DOI
  3. World Health Organization, 2012, The weekly epidemiological record, Geneva, p201
  4. Ortiz, 2016, A global review of national influenza immunization policies: analysis of the 2014 WHO/UNICEF joint reporting form on immunization, Vaccine, 34, 5400, 10.1016/j.vaccine.2016.07.045 · DOI
  5. Fleming, 2018, Implementation of maternal influenza immunization in El Salvador: experiences and lessons learned from a mixed-methods study, Vaccine, 36, 4054, 10.1016/j.vaccine.2018.05.096 · DOI
  6. Maertens, 2016, Maternal pertussis and influenza immunization coverage and attitude of health care workers towards these recommendations in Flanders Belgium, Vaccine, 34, 5785, 10.1016/j.vaccine.2016.09.055 · DOI
  7. Moreno-Pérez, 2017, Immunisation schedule of the Spanish association of paediatrics: 2018 recommendations, Analesdepediatria, 88
  8. Australian technical advisory group on immunisation. The Australian immunisation handbook. 10th edition ed. Canberra: australian government department of health and ageing; 2013.
  9. Amirthalingam, 2016, Sustained Effectiveness of the maternal pertussis immunization program in England 3 years following introduction, Clin Infect Dis, 63, S236, 10.1093/cid/ciw559 · DOI · Paper page
  10. Dabrera, 2015, A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012–2013, Clin Infect Dis, 60, 333, 10.1093/cid/ciu821 · DOI · Paper page
  11. Baxter, 2017, Effectiveness of vaccination during pregnancy to prevent infant pertussis, Pediatrics, 139, 10.1542/peds.2016-4091 · DOI
  12. Bellido-Blasco, 2017, A case-control study to assess the effectiveness of pertussis vaccination during pregnancy on newborns, valencian community, Spain, 1 March 2015 to 29 February 2016, Euro Surveill, 22, 10.2807/1560-7917.ES.2017.22.22.30545 · DOI
  13. Winter, 2017, Effectiveness of prenatal tetanus, diphtheria, and acellular pertussis vaccination on pertussis severity in infants, Clin Infect Dis, 64, 9, 10.1093/cid/ciw633 · DOI
  14. Byrne, 2018, Hospitalisation of preterm infants with pertussis in the context of a maternal vaccination programme in England, Arch Dis Child, 103, 224, 10.1136/archdischild-2016-311802 · DOI
  15. Skoff, 2017, Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants <2 months of age: a case-control evaluation, Clin Infect Dis, 65, 1977, 10.1093/cid/cix724 · DOI
  16. Shi, 2017, Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study, Lancet (Lond England), 390, 946, 10.1016/S0140-6736(17)30938-8 · DOI
  17. Seale, 2017, Estimates of the burden of group b streptococcal disease worldwide for pregnant women, stillbirths, and children, Clin Infect Dis, 65, S200, 10.1093/cid/cix664 · DOI · Paper page
  18. Leroux-Roels, 2016, A randomized, observer-blind phase Ib study to identify formulations and vaccine schedules of a trivalent group B streptococcus vaccine for use in non-pregnant and pregnant women, Vaccine, 34, 1786, 10.1016/j.vaccine.2016.02.044 · DOI
  19. Baker, 2003, Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III, J Infect Dis, 188, 66, 10.1086/375536 · DOI
  20. Baker, 2003, Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine, Vaccine, 21, 3468, 10.1016/S0264-410X(03)00353-0 · DOI
  21. Baker, 1999, Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib, J Infect Dis, 179, 142, 10.1086/314574 · DOI
  22. Baker, 2004, Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines, J Infect Dis, 189, 1103, 10.1086/382193 · DOI
  23. Madhi, 2016, Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial, Lancet Infect Dis, 16, 923, 10.1016/S1473-3099(16)00152-3 · DOI
  24. Heyderman, 2016, Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial, Lancet Infect Dis, 16, 546, 10.1016/S1473-3099(15)00484-3 · DOI
  25. Edmond, 2012, Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis, Lancet, 379, 547, 10.1016/S0140-6736(11)61651-6 · DOI · Paper page
  26. MacDougall, 2016, Improving rates of maternal immunization: Challenges and opportunities, Human Vaccin Immun, 12, 857, 10.1080/21645515.2015.1101524 · DOI
  27. McQuaid, 2018, Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation, Acta Obstet Gynecol Scand, 97, 330, 10.1111/aogs.13288 · DOI
  28. McQuaid, 2016, Factors influencing women’s attitudes towards antenatal vaccines, group B streptococcus and clinical trial participation in pregnancy: an online survey, BMJ Open, 6, e010790, 10.1136/bmjopen-2015-010790 · DOI
  29. Dempsey, 2014, Acceptability of a hypothetical group B strep vaccine among pregnant and recently delivered women, Vaccine, 32, 2463, 10.1016/j.vaccine.2014.02.089 · DOI
  30. Krishnaswamy, 2017, Protecting newborns from pertussis: The role of partner vaccination in the era of maternal immunization, Eur J Obstet Gynecol Reprod Biol, 216, 159, 10.1016/j.ejogrb.2017.07.031 · DOI
  31. Krishnaswamy, 2018, Understanding the barriers to uptake of antenatal vaccination by women from culturally and linguistically diverse backgrounds: a cross-sectional study, Hum Vaccin Immun, 14, 1591, 10.1080/21645515.2018.1445455 · DOI
  32. Le Doare, 2017, Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: systematic review, Clin Infect Dis, 65, S143, 10.1093/cid/cix654 · DOI
  33. Wiley, 2015, Understanding pregnant women’s attitudes and behaviour toward influenza and pertussis vaccination, Qual Health Res, 25, 360, 10.1177/1049732314551061 · DOI
  34. Jones, 2016, Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women, Vaccine, 34, 5998, 10.1016/j.vaccine.2016.07.032 · DOI
  35. Jones, 2016, Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy, Vaccine, 34, 6007, 10.1016/j.vaccine.2016.07.007 · DOI
  36. Nair, 2013, Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis, Lancet, 381, 1380, 10.1016/S0140-6736(12)61901-1 · DOI · Paper page
  37. Shi, 2017, Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study, Lancet, 390, 946, 10.1016/S0140-6736(17)30938-8 · DOI

Metadata

Authors
Giles, M. L., Buttery, J., Davey, M.-A., & Wallace, E.
Venue
Vaccine
Publisher
Elsevier BV
Published
2019-10
Volume
37
Issue
44
Pages
6743-6749
ISSN
0264-410X
DOI
10.1016/j.vaccine.2019.08.084
Cited by
56
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review